Private Equity

VC Fund Investments

Cancer treatment player Zumutor raises $6.2 M from Siana Capital, Accel, BIF

Inc42  

Bengaluru and Boston based biotech startup Zumutor Biologics has raised USD 6.2 million in its Series A4 funding round led by Siana Capital along with existing investors Accel and Bharat Innovation Fund. The funding would help the startup to file for the phase 1 clinical trial of ‘ZM008', an NK (natural killer) cell activating antibody for prostate cancer, in the US. Founded by Kavitha Iyer Rodrigues in 2013, the biotech startup had raised USD 4 million from Bharat Innovation Fund and Accel Partners in 2019. Zumutor develops NK cells therapeutics with a first-in-class antibody to treat prostate cancer.